Research Associate Professor
BiographyDr. Victor D. Rosenthal is a Research Associate Professor at the Division of Epidemiology and Population Health Sciences, in the Department of Public Health Sciences, at the Leonard M. Miller School of Medicine, at the University of Miami, where he continues his groundbreaking work in infection prevention.
He is a medical doctor specialized in internal medicine, infectious diseases, infection control, and hospital epidemiology. He was one of the first people to study health care-associated infections (HAIs) and how to stop bacterial resistance in low- and middle-income countries (LMICs). He is the founder and chairman of the International Nosocomial Infection Control Consortium (INICC) Foundation, a non-profit international research center that focuses on HAIs, leading trials and doing groundwork with over 2,000 researchers in 800 ICUs, in 150 cities of 50 countries in Africa, Asia, Eastern Europe, and Latin America.
After finishing medical school at the University of Buenos Aires in Argentina and specializing in internal medicine and infectious diseases, Dr. Rosenthal started studying HAIs at the Association for Professionals in Infection Control and Epidemiology, the Society for Hospital Epidemiology of America, and the Joint Commission on Healthcare Accreditation. Dr. Rosenthal created the INICC and gave services and training at LMICs after he realized that most of the patients he saw for diagnosing and treating infectious diseases were infected because of medical care.
He took it upon himself to stop the spread of HAIs in LMICs. He did this by helping healthcare workers (HCW) use software he made to monitor, research, prevent HAIs and reduce bacterial resistance, as well as by sharing his knowledge and methods.
Dr. Rosenthal has helped the governments of Hong Kong, Taiwan, Peru, Colombia, Brazil, and Argentina, as well as the International Society of Infectious Diseases (ISID) and the Joint Commission International, come up with and edit guidelines for preventing HAIs. He has worked with the World Health Organization (WHO) to review their hand hygiene guidelines, guidelines for controlling bacterial resistance, and primary data to raise awareness of healthcare-associated infections (HAIs) and how they affect developing countries. He has also worked with the Centers for Disease Control and Prevention (CDC) to create an online software in 16 languages for monitoring multidrug-resistant tuberculosis around the world.
He has also conducted research in cooperation with Oxford University and several other universities. He is also on the Editorial Boards of the American Journal of Infection Control, the Journal of Infection and Public Health, and the Annals of Clinical Microbiology and Antimicrobials.
He is also a peer reviewer for more than a hundred peer-reviewed journals, including The Lancet, that are listed at the National Library of Medicine of the National Institutes of Health, Pubmed. He is also part of the Health Improvement Planning, Division of Public Health Statistics and Performance Management, Florida Department of Health, Transmissible and Emerging Diseases (TED) Priority Area Workgroup (PAW). He has also been collaborating in the area of surveillance and prevention of HAI with the infection control team at Jackson Memorial Hospital.
Over 90% of the scientific papers with primary HAI data from LMICs that have been published so far were written by Dr. Rosenthal and his INICC group.
He has written 390 scientific papers and book chapters, including several in Bennett & Brachman's Hospital Infections, which is the best-selling and most-used book on preventing HAIs in the United States and around the world.
His work has now been cited 12,500 times, for a h-index of 60. He has won 10 major international awards for his work, including the Blue Ribbon Award, the Best International Abstract Award, the Award for Publication Excellence from the Association for Professionals in Infection Control and Epidemiology of America, and the SHEA William Jarvis Award from the Society for Hospital Epidemiology of America.
His desire to share what he knows has taken him all over the world. He has spent his entire career helping healthcare workers stop the spread of HAIs and reduce bacterial resistance. For the last 30 years, he has shared his expertise as a speaker at conferences and symposiums all over the world.
His efforts have provided invaluable contributions to the prevention of HAIs, particularly in Africa, Asia, Eastern Europe, and Latin America, by training HCWs, introducing effective solutions, coordinating research efforts, and saving uncountable lives. Dr. Rosenthal’s efforts are fueled by a simple goal: saving lives in LMICs.
Education & Training
Licensures and Certifications
Honors & Awards
No result found
Research InterestsSurveillance, Prevention, and Control of Health Care-Associated Infections and Multi-Drug Resistant Organisms